Allgrove or triple A syndrome is a rare autosomal recessive disorder that can present with a variable range of multi-system manifestations, including optic atrophy, cerebellar ataxia, upper and lower motoneuron signs and various neuropathic abnormalities. These cases are a diagnostic challenge, particularly when the eponymous combination of achalasia, Addisonianism and alacrima is incomplete. Therefore, it is in the differential diagnosis for multisystem conditions and should be known to pathologists who diagnose disorders of skeletal muscle. Here, we describe new findings in skeletal muscle histology from the case of a boy of consanguineous Turkish origin whose achalasia provided the only specific clinical clue to the diagnosis. These include myocyte nuclear abnormalities with partially abnormal anti-lamin A/C immunohistochemistry and altered nuclear ultrastructure but without overt abnormalities of nuclear pore morphology. In this case, the condition was associated with a hitherto unreported c.762delC mutation in the nucleoporin gene AAAS.
INTRODUCTION
Allgrove or triple A syndrome is an autosomal-recessive disorder that is mostly caused by mutations in the AAAS gene, which codes for the nucleoporin ALADIN (1, 2) . A similar combination of achalasia, alacrima and neurological deficits (but so far without adrenal insufficiency) has been found in an autosomal-recessive condition caused by mutations in the GMPPA gene (3) . The precise pathological mechanism of either disease remains yet unknown but effects on nucleocytoplasmic transport have been implicated (4) and recent research also suggests an influence on mitotic spindle formation (5) in AAAS mutations.
Because the triad of achalasia, Addisonianism and alacrima is frequently incomplete (6) and other neurological signs from the broad range of associated symptoms including optic atrophy, cerebellar ataxia, upper and lower motoneuron signs as well as various neuropathic presentations (7) may predominate, clinically this can be a difficult differential diagnosis. This is particularly problematic when atrophy of the tongue, widespread neurogenic muscle damage, and upper motor neuron signs lead to the suggestion of the diagnosis of juvenile amyotrophic lateral sclerosis.
Although there are a number of case reports and collections, morphological descriptions of the affected tissues are rare and usually restricted to findings in peripheral nerves (7) . By contrast, there are detailed histopathology reports for other disorders affecting nuclear components, for example, in Emery-Dreifuss muscular dystrophies (8) .
MATERIALS AND METHODS

Case History
A 10-year-old boy, the product of a normal pregnancy, was the third child of a consanguineous Turkish couple who presented with declining school performance following normal early development. Impaired coordination, concentration and general endurance was found. Brisk reflexes, clumsy movements and subsequently distal tetraparesis subsequently developed. At the age of 17, he was slim with signe des cils (incomplete eye closure), high, arched palate, slightly atrophic tongue, mild scoliosis and minor funnel chest. Deep tendon reflexes were very brisk but muscle tone and plantar response normal. Atrophy of the hand muscles, calves and less marked of the shoulder girdle muscles with weakness of finger extension and toe dorsiflexion (MRC 3) as well as foot dorsiflexion, hip and arm extension (MRC 4) were found. Sensory and pure coordination exams were normal.
Laboratory investigations, including metabolic screening, were unremarkable except for a creatine kinase of >500 U/l. Neurophysiology examinations showed mild axonal motor neuropathy with neurogenic changes in hand and calf muscles. Genetic testing including karyogram, PMP22, DKMP, CNBP and SMN1 genes gave normal results. Neuromuscular complaints were not reported by his adult brother and sister or his parents. No ophthalmological abnormalities were known nor were there cardiac symptoms or blood sugar disturbances; a lack of tears was denied.
Finally, a worsening tendency to choke on food led to the diagnosis of type II achalasia. This raised the suspicion of triple A syndrome, prompting genetic testing which confirmed this diagnosis.
Morphology
Analysis of sural nerve histology was performed with standard and immunohistochemical stains on 4-to 5-mm-thick sections of formalin-fixed, paraffin-embedded tissue and with toluidine blue-stained semi-thin sections of glutaraldehydefixed, Epon-embedded tissue. Standard histochemical, enzyme histochemical and immunohistochemical stains were performed on 6-mm-thick cryosections of the gastrocnemius muscle. Monoclonal mouse antibodies against lamin A/C (1:100, IgG2b, clone 636; Novocastra, Leica Biosystems, Newcastle, UK), emerin (1:50, IgG1, clone 4G5; Novocastra), ALADIN (1:250, IgG2a, ab56384, Abcam, Cambridge, UK) and GAPDH (1:150,000, IgG1, ab8245, Abcam), as well as a polyclonal rabbit antibody against lamin A (1:400, ab26300, Abcam) that reacts with the carboxy terminal end of lamin A (i.e. the only part of the protein not present in lamin C) were used for the reactions presented. For electron microscopy, the muscle was fixed in 3% glutaraldehyde with 0.1 M HEPES, later progressively dehydrated in a graded series of ethanol and embedded in Epon C. Ultrathin sections (50-60 nm) were stained and contrasted with uranyl acetate and lead citrate.
Molecular Studies
RNA was extracted from frozen muscle tissue from the index patient and 2 gender-and age-matched controls using RNeasy Mini Kit (Qiagen, Hilden, Germany). Reverse transcription was carried out using GoScript TM Reverse Transcription System (Promega, Mannheim, Germany) and 5 mg of muscle RNA. Two hundred ng of the resulting cDNA was used for PCR using primers generating an amplicon potentially covering the ALADIN mutation. Seven ml of PCR products were tested via agarose-gel electrophoresis before Sanger sequencing of ExoSAP-IT (Affymetrix, High Wycombe, UK) processed amplicons was carried out. Formal consent for scientific use of residual tissue was obtained at the time of biopsy as approved by the local ethics committee (069/03 and 070/03). Due to the retrospective/diagnostic character of this study no further statements were required.
RESULTS
Light Microscopy
The sural nerve biopsy did not show relevant abnormalities. The muscle biopsy showed considerable fatty replacement, increased endo-and perimysial connective tissue, many rounded myofiber profiles and increased fiber size variability (Fig. 1A) . Atrophic fibers often showed angulated profiles and formed small groups. Internalized myonuclei were increased and some pyknotic nuclear clumps were found. There were numerous degenerating and some regenerating fibers, fiber splitting and many whorled fibers, some rimmed vacuoles and a few vacuoles without a rim, mostly with slightly eosinophilic content. Inflammatory infiltrates were absent and intramuscular vessels appeared normal.
Both fiber types contributed to the atrophic and hypertrophic fiber populations but more type II than type I fibers were atrophic and vice versa for the hypertrophic fibers, with some fiber type grouping (Fig. 1D) , albeit with split fibers increasing the perceived number of fiber profiles in a "group" and clusters frequently including less than 16 fibers. NADH stain showed numerous small dark fibers and few target fibers, more frequently targetoid/core-like lesions. Some atrophic fibers reacted dark with the nonspecific esterase stain (Fig. 1G) . There was no storage of lipids or PAS-positive material or deposition of congophilic, birefringent substances. Acid phosphatase stain showed fine foci of sarcoplasmic staining in many fibers. Additional enzyme histochemistry (myoadenylate deaminase, myophosphorylase, succinate dehydrogenase and phosphofructokinase) was unremarkable except for 3 cytochrome c-oxidase-negative fibers.
Immunohistochemistry showed normal reactivities with antibodies against dystrophin, the sarcoglycans, a-dystroglycan, merosin, emerin, desmin, caveolin 3, collagen IV and collagen VI. Surprisingly, reactivity of numerous nuclei with anti-lamin A/C was clearly reduced, particularly in comparison to anti-emerin reactivity (Fig. 1B, C) . However, this reduction was not evident with a polyclonal anti-lamin A antibody (Fig. 1E, F, H, I ).
Electron Microscopy
By electron microscopy, no sarcolemmal abnormalities but focal subsarcolemmal increases of glycogen and fine filamentous structures were detected. There were foci of disorganized myofibrils, occasionally associated with membrane bound vacuoles of variable size, most likely dilatations of sarcoplasmic reticulum, containing a fine granular structure showing little contrast ( Fig. 2A) . Some mitochondria had dilated cristae. Many myonuclei showed relatively sparse, peripheral heterochromatin, and invaginations were repeatedly seen, leading to pseudoinclusions (Fig. 2B) . A tubulofilamentous inclusion was found in 1 myonucleus (Fig. 2C) . The tubulofilaments were arranged in bundles and showed diameters of 44 to 70 nm. Nuclear pores were of normal morphology and size (Fig. 2D, E) .
Further Analysis
Commercial analysis of AAAS gene detected the previously undescribed homozygous mutation c.762delC, p.S255Vfs*35 resulting in a frame shift theoretically leading to a premature stop codon (nucleotide position 869). This mutation was confirmed in the heterozygous state in the asymptomatic parents and brother. However, Western blot analysis of the patient's muscle demonstrated a band of only marginally lower weight with about half the intensity of control muscle (Fig. 2F) . Analysis of mRNA clarified these apparently contradictory findings by proving the presence of transcripts including the mutation, but without premature stop. Upper panels: normal muscle, lower panels, triple A case. Note that many nuclei in the biopsy of the triple A case show considerably less lamin A/C than emerin immunoreactivity (e.g. surrounding the asterisk and marked by the arrowheads). This is never the case in the control. (D) ATPase reaction after preincubation at pH 4.6 for differentiation of fiber types. Note the grouping of fibers of equal reactivity but also that few of these clusters reach 15 fibers or more; split fibers contribute to the number of equal reactivity profiles within these clusters. (E,F) Immunohistochemistry for lamin A/C (E) and lamin A (F) of the triple A case. Note that while the overall stronger anti-lamin A reactivity generally varies in parallel with anti-lamin A/C reactivity, some nuclei show disproportionally less anti-lamin A/C. This includes very few nuclei that cannot be detected by anti-lamin A/C at all, but show anti-lamin A reactivity (e.g. the nucleus indicated by the arrowhead). 
DISCUSSION
Skeletal muscle histopathology in this case revealed changes indicative of neurogenic damage, in particular with fiber type grouping and the esterase reaction; as in most case descriptions, neurogenic changes seem to dominate the clinical picture. However, some of our findings, such as the many rounded fibers, the extent of the increase of endomysial connective tissue and fatty replacement, as well as sarcoplasmic acid phosphatase foci are beyond what many will accept as "pseudomyopathic changes in chronic partial denervation" (9), thereby assigning it to the uneasy label of "mixed pathology". The nuclear abnormalities demonstrated here by immunohistochemistry and electron microscopy seem to be too nonspecific and polymorphic to be diagnostic when considered in isolation. However, such changes would not be expected in neurogenic muscle damage. Future cases might clarify how useful a clue to the diagnosis they are. Epitope masking is a possible explanation for the changes in our anti-lamin A/C immunohistochemistry, as similar findings in other anti-lamin immunohistochemistry have been described (10) , and this would be consistent with both the preserved anti-emerin and the anti-lamin A reactivities.
In our work-up to prove causation of the disease by the new mutation detected, we discovered that the ALADIN Western blot did not show the absence of the protein or the truncation suggested by DNA analysis. RNA analysis then revealed that this is a case that is complicated by stop codon read-through, likely in combination with partial non-sense mediated decay of RNA or protein instability. Particularly in rare and complicated cases without established genotypephenotype data, availability of tissue samples for protein and mRNA analysis is highly recommended for both, confirming a diagnosis and possibly gaining insight in the pathophysiology of the disorder.
